IOWA CITY, IOWA – iotaMotion, Inc., a leader in innovative surgical solutions for cochlear implantation, has announced that its iotaSoft® robotic-assisted insertion system is now in use at 25 cochlear implant centers across the United States. The company has also secured Series B funding to further accelerate its expansion in 2025.
The iotaSoft system is designed to assist surgeons in the precise and controlled insertion of cochlear implant electrodes, aiming to enhance patient outcomes and improve the surgical process.
The system enables fine control of electrode advancement, with the goal of preserving delicate cochlear structures during implantation.
“We are incredibly proud of the impact the iotaSOFT Insertion System has had on the cochlear implant market. Creating a market for robotic assistance and then subsequently generating demand for the technology has resulted in some of our centers demonstrating a 20% increase year over year cochlear implant program growth compared to the market average of 7%.”
–Mike Lobinsky, President & CEO of iotaMotion
Jeff Hopkins
Looking ahead to 2025, iotaMotion is positioned to continue its commercial expansion. With Series B funding secured, the company plans to use the capital to scale its operations while advancing innovations in cochlear implantation. The funding round also included an expansion of the Board of Directors with the addition of Jeff Hopkins.
A seasoned leader with 30 years of experience in medical technology, Hopkins has a track record of driving strategic growth and enhancing value for patients and healthcare providers. He previously led Johnson & Johnson’s Acclarent ENT business through a successful turnaround and expansion into the otology and cranial navigation guidance markets.
“I am excited to take an active role on the board of iotaMotion as they disrupt the cochlear implant industry,” said Hopkins. “The technology is impactful for patients with advanced hearing loss and will broaden adoption of neurotology treatments.”
“The completion of our Series B round and addition of Jeff Hopkins to our board, coming on the heels of an exceptional first full year of commercialization, underscores the market’s confidence in our technology. 2025 will be a year marked by rapid commercial growth and continued success in building a robotic-assisted market for cochlear implantation.”
—Mike Lobinsky, President & CEO of iotaMotion
**Readers may be interested to view this past interview with Wade Colburn and Dr. Marlan Hansen of iotaMotion
About iotaMotion
iotaMotion, Inc. is a medical technology company based in St. Paul, MN, dedicated to advancing the outcomes of cochlear implantation through innovative, robotic-assisted solutions. The company’s flagship product, the iotaSOFT® Insertion System, offers a groundbreaking approach to cochlear implant surgery by providing enhanced control beyond the capability of a human hand during electrode array insertion. iotaMotion aims to provide hearing professionals with tools to improve patient outcomes and preserve intracochlear structures.
Source: iotaMotion
